Clinical Features and Genetic Risk of Demyelination Following Anti-TNF Treatment.
Saved in:
| Title: | Clinical Features and Genetic Risk of Demyelination Following Anti-TNF Treatment. |
|---|---|
| Authors: | Lin, Simeng1,2 (AUTHOR) tariq.ahmad1@nhs.net, Green, Harry D1 (AUTHOR), Hendy, Peter1,2 (AUTHOR), Heerasing, Neel M1,2 (AUTHOR), Chanchlani, Neil1 (AUTHOR), Hamilton, Benjamin1 (AUTHOR), Walker, Gareth J1,2 (AUTHOR), Heap, Graham A1,2 (AUTHOR), Hobart, Jeremy3 (AUTHOR), Martin, Roswell J4 (AUTHOR), Coles, Alasdair J5 (AUTHOR), Silverberg, Mark S6 (AUTHOR), Irving, Peter M7 (AUTHOR), Chung-Faye, Guy8 (AUTHOR), Silber, Eli9 (AUTHOR), Cummings, J R Fraser10 (AUTHOR), Lytvyak, Ellina11 (AUTHOR), Andersen, Vibeke12 (AUTHOR), Wood, Andrew R13 (AUTHOR), Tyrrell, Jessica13 (AUTHOR) |
| Source: | Journal of Crohn's & Colitis. Dec2020, Vol. 14 Issue 12, p1653-1661. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
